Targeting neutrophils in asthma: A therapeutic opportunity?

This publication has 179 references indexed in Scilit:

• The Receptor for Advanced Glycation End Products Is a Central Mediator of Asthma Pathogenesis
  The American Journal of Pathology, 2012
• Interleukin-1α controls allergic sensitization to inhaled house dust mite via the epithelial release of GM-CSF and IL-33
  Journal of Experimental Medicine, 2012
• Mechanisms of Action and Clinical Application of Macrolides as Immunomodulatory Medications
  Clinical Microbiology Reviews, 2010
• Th17 Immunity in Patients with Allergic Asthma
  International Archives of Allergy and Immunology, 2009
• Montelukast inhibits neutrophil pro‐inflammatory activity by a cyclic AMP‐dependent mechanism
  British Journal of Pharmacology, 2008
• ERK-mediated regulation of leukotriene biosynthesis by androgens: A molecular basis for gender differences in inflammation and asthma
  Proceedings of the National Academy of Sciences, 2008
• Reduction in sputum neutrophil and eosinophil numbers by the PDE4 inhibitor roflumilast in patients with COPD
  Thorax, 2007
• Distinct regulation of interleukin‐17 in human T helper lymphocytes
  Arthritis & Rheumatism, 2007
• Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17–producing human T helper cells
  Nature Immunology, 2007
• Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
  Nature, 2006